f****X
发帖数: 64 | 2 DNDN的问题很复杂， Matthew Herper的这篇文章很值的参考一下
How many patients actually want to take Provenge, and how many doctors want
to prescribe it?
No one has a good answer.
The new problem facing Provenge, which Dendreon is calling “cost density,”
would certainly explain what went wrong in the quarter. Not only is
Provenge very expensive ($93,000 per patient), but doctors must outlay all
this cost themselves until Medicare or insurance companies pay them back.
David Miller of Biotech Stock Research, a longtime... 阅读全帖 |
|
